# Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML

> **NCT04908852** · — · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 10 (actual)

## Conditions studied

- Acute Myeloid Leukemia (AML)

## Interventions

- **OTHER:** Blood Sample Collection - Observational Study
- **OTHER:** Symptom questionnaires - Observational Study

## Key facts

- **NCT ID:** NCT04908852
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-26
- **Primary completion:** 2023-02-23
- **Final completion:** 2023-02-23
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-04-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908852, "Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04908852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*